Crimson Publishers Publish With Us Reprints e-Books Video articles


Open Access Research in Anatomy

CRISPR Applications Versus the Ethical and Regulatory Concerns

  • Open or Close Ahmed T M Elshennawy*

    Department of Anatomy, Faculty of Medicine, Al-Baha University, Saudi Arabia/p>

    *Corresponding author: Ahmed T M Elshennawy, Department of Anatomy, Faculty of Medicine, Al-Baha University, Saudi Arabia

Submission: December 12, 2020; Published: January 28, 2021

DOI: 10.31031/OARA.2021.02.000540

ISSN: 2577-1922
Volume2 Issue3


CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) has many applications such as editing the human genome and CRISPR-edited crops as well as CRISPRedited animals for the use of human organ transplants [1-4]. However, are the applications of CRISPR ethically defensible or not? For simplification, I will go through one example, the CRISPR-edited animals for the use of human organ transplants, where CRISPR-gene editing solves the problem occurring with the traditional use of PSCs (Pluripotent Stem Cells) or iPSCs (Induced Pluripotent Stem Cells) to produce differentiated β-cells of pancreatic islets of Langerhans to treat type 1 diabetes and the subsequent fatigue of these transplanted stem cells and failure to produce insulin and recurrence of diabetes again.

Get access to the full text of this article

About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137